Open source drug discovery in practice: a case study.

by Christine Årdal, John-Arne Røttingen
Published 2012-01-01

An open source business model for malaria.

by Christine Årdal, John-Arne Røttingen
Published 2015-01-01

A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG).

by John-Arne Røttingen, Claudia Chamas
Published 2012-01-01

Trends in health policy and systems research over the past decade: still too little capacity in low-income countries.

by Taghreed Adam, Saad Ahmad, Maryam Bigdeli, Abdul Ghaffar, John-Arne Røttingen
Published 2011-01-01

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations

by Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen
Published 2018-04-01

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

by Kevin Outterson, Unni Gopinathan, Charles Clift, Anthony D So, Chantal M Morel, John-Arne Røttingen
Published 2016-06-01

A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries

by Marc Mendelson, Osman A. Dar, Steven J. Hoffman, Ramanan Laxminarayan, Mirfin M. Mpundu, John-Arne Røttingen
Published 2016-10-01

Antimicrobial resistance: The complex challenge of measurement to inform policy and the public.

by Didier Wernli, Peter S Jørgensen, Stephan Harbarth, Scott P Carroll, Ramanan Laxminarayan, Nicolas Levrat, John-Arne Røttingen, Didier Pittet
Published 2017-08-01

The effect of generic market entry on antibiotic prescriptions in the United States

by Cecilia Kållberg, Jemma Hudson, Hege Salvesen Blix, Christine Årdal, Eili Klein, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
Published 2021-05-01

The Joint Action and learning initiative: towards a global agreement on national and global responsibilities for health.

by Lawrence O Gostin, Eric A Friedman, Gorik Ooms, Thomas Gebauer, Narendra Gupta, Devi Sridhar, Wang Chenguang, John-Arne Røttingen, David Sanders
Published 2011-05-01

Introduction and geographic availability of new antibiotics approved between 1999 and 2014.

by Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, Eili Klein, Elena M Martinez, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
Published 2018-01-01

Guidance for evidence-informed policies about health systems: linking guidance development to policy development.

by John N Lavis, John-Arne Røttingen, Xavier Bosch-Capblanch, Rifat Atun, Fadi El-Jardali, Lucy Gilson, Simon Lewin, Sandy Oliver, Pierre Ongolo-Zogo, Andy Haines
Published 2012-01-01

A global biomedical R&D fund and mechanism for innovations of public health importance.

by Manica Balasegaram, Christian Bréchot, Jeremy Farrar, David Heymann, Nirmal Ganguly, Martin Khor, Yves Lévy, Precious Matsoso, Ren Minghui, Bernard Pécoul, Liu Peilong, Marcel Tanner, John-Arne Røttingen
Published 2015-05-01

Guidance for evidence-informed policies about health systems: assessing how much confidence to place in the research evidence.

by Simon Lewin, Xavier Bosch-Capblanch, Sandy Oliver, Elie A Akl, Gunn E Vist, John N Lavis, Davina Ghersi, John-Arne Røttingen, Peter Steinmann, Metin Gulmezoglu, Peter Tugwell, Fadi El-Jardali, Andy Haines
Published 2012-01-01

Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

by Dimitrios Gouglas, MSc, Tung Thanh Le, MSc, Klara Henderson, PhD, Aristidis Kaloudis, ProfPhD, Trygve Danielsen, MSc, Nicholas Caspersen Hammersland, MSc, James M Robinson, MS, Penny M Heaton, MD, John-Arne Røttingen, ProfMD
Published 2018-12-01

Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development.

by Xavier Bosch-Capblanch, John N Lavis, Simon Lewin, Rifat Atun, John-Arne Røttingen, Daniel Dröschel, Lise Beck, Edgardo Abalos, Fadi El-Jardali, Lucy Gilson, Sandy Oliver, Kaspar Wyss, Peter Tugwell, Regina Kulier, Tikki Pang, Andy Haines
Published 2012-01-01

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.

by Philippe J Guerin, Lisbeth M Naess, Carole Fogg, Einar Rosenqvist, Loretxu Pinoges, Francis Bajunirwe, Carolyn Nabasumba, Ray Borrow, Leif O Frøholm, Salah Ghabri, Vincent Batwala, Rogers Twesigye, Ingeborg S Aaberge, John-Arne Røttingen, Patrice Piola, Dominique A Caugant
Published 2008-01-01

Evidence Synthesis International (ESI): Position Statement

by David Gough, Phil Davies, Gro Jamtvedt, Etienne Langlois, Julia Littell, Tamara Lotfi, Edoardo Masset, Tracy Merlin, Andrew S. Pullin, Merel Ritskes-Hoitinga, John-Arne Røttingen, Emily Sena, Ruth Stewart, David Tovey, Howard White, Jennifer Yost, Hans Lund, Jeremy Grimshaw
Published 2020-07-01